Recent reports indicate that up to 20% of patients using popular obesity medications like Wegovy and Mounjaro may not experience significant weight loss. Experts emphasize the variability in individual responses to these treatments, urging realistic expectations among users. This highlights the complexities of obesity treatment and the need for personalized approaches.